Haemonetics HAE Rest of Asia — Net revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's rest of asia — net revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's rest of asia — net revenues?
- Haemonetics (HAE) reported rest of asia — net revenues of $19.97M in Q1 2026.
- How has Haemonetics's rest of asia — net revenues changed year-over-year?
- Haemonetics's rest of asia — net revenues decreased by 5.6% year-over-year, from $21.16M to $19.97M.
- What is the long-term trend for Haemonetics's rest of asia — net revenues?
- Over 4 years (2022 to 2026), Haemonetics's rest of asia — net revenues has grown at a -5.8% compound annual growth rate (CAGR), from $110.8M to $87.21M.
- What does rest of asia — net revenues mean?
- This metric measures the total sales generated from products and services provided by the company within the Rest of Asia geographic market, net of returns, allowances, and discounts. It serves as a primary indicator of the company's market penetration, demand, and competitive success within this specific region. Tracking this revenue stream allows stakeholders to evaluate the performance and growth trajectory of the company's international expansion efforts.